ArticleJournal of cancer research and clinical oncology2023

Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE.

Kun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.